Back
Lonza Group Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
58
LZAGY
Lonza Group
Last Price:
$69.79
Seasonality Move:
7.88%
Buy
60
NLSP
NLS Pharmaceutics
Last Price:
$2.73
Seasonality Move:
-17.66%
Buy
58
Lonza Group (LZAGY)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
-
The current Lonza Group [LZAGY] share price is $69.66. The Score for LZAGY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
LZAGY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
NLS Pharmaceutics (NLSP)
is a Buy
Is NLS Pharmaceutics a Buy, Sell or Hold?
-
The current NLS Pharmaceutics [NLSP] share price is $2.30. The Score for NLSP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
NLSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LZAGY Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $69.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LZAGY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $2.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
LZAGY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 55.62 | Buy |
Chaikin Money Flow: | 60480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.78 - 70.66) | Buy |
Bollinger Bands (100): | (62.2 - 68.96) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 65.15 | Buy |
Chaikin Money Flow: | 577631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.62 - 2.12) | Buy |
Bollinger Bands (100): | (1.47 - 2.07) | Buy |
LZAGY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.78 | Buy |
20-day SMA: | 68.68 | Buy |
50-day SMA: | 67.17 | Buy |
200-day SMA: | 63.73 | Buy |
8-day EMA: | 68.85 | Buy |
20-day EMA: | 68.73 | Buy |
50-day EMA: | 67.6 | Buy |
200-day EMA: | 63.55 | Buy |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.18 | Buy |
20-day SMA: | 1.91 | Buy |
50-day SMA: | 1.66 | Buy |
200-day SMA: | 2.93 | Sell |
8-day EMA: | 2.11 | Buy |
20-day EMA: | 1.96 | Buy |
50-day EMA: | 1.82 | Buy |
200-day EMA: | 3.81 | Sell |
Lonza Group Earnings Growth & LZAGY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lonza Group Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |